Table 3.
Sensitivity analysis of 5% variation in model inputs
Cost/QALY Low | Cost/QALY High | Cost-effectiveness | |
---|---|---|---|
reSET-O Cost | -$92,542.43 | -$80,272.49 | economically dominant (less costly, more effective) |
Buprenorphine cost | -$86,407.46 | -$86,407.46 | |
Cost of CM | -$84,916.33 | -$87,898.60 | |
Costs not retained | -$78,615.80 | -$94,199.13 | |
Utilities Retained | -$182,980.51 | -$41,753.94 | |
Utilities Not Retained | -$44,122.96 | -$2,073,779.14 |